The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule.

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals.

Vaccine maker Moderna says the Food and Drug Administration will decide whether to approve its new flu shot for older adults after all.

The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with mRNA technology.

A dozen prior leaders of the U.S. Food and Drug Administration issued a scathing denunciation of an FDA memo to staff that made sweeping claims casting doubt on vaccine safety.

The Food and Drug Administration has named a longtime regulator of cancer medications to lead the agency’s drug center.

The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct.

Defense Secretary Pete Hegseth says the U.S. military is moving forward with plans to build a dedicated facility in Idaho to train pilots from Qatar, an important U.S. ally in the Middle East.

The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy.

The top ranking Democrat on the Senate Intelligence Committee says a classified meeting planned with a key U.S. spy agency was called off after it was criticized by Laura Loomer, a far-right conspiracy theorist.

A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top vaccine regulator.

President Donald Trump has downplayed the influence of Laura Loomer, a right-wing provocateur known for her incendiary social media presence, in his administration’s decision-making.

Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure.

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program.

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines.

The Department of Health and Human Services under Robert F.

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.

Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this fall and winter.

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy.

Health agencies working under Robert F.

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its vaccine center.

An eight-year project to carefully repeat early but influential lab experiments in cancer research has reached a conclusion.